Seroquel XR approved for adjunctive treatment of major depressive disorder (MDD) - MPR
Links shared publicly online about this topic.
- 1,548total visits
Seroquel XR approved for adjunctive treatment of major depressive disorder (MDD) - MPR
empr.com —
View full resource at empr.com
Tags: Antidepressant, Major Depression, Schizophrenia Medication, Antipsychotic Medication, Disease and Condition, FDA, Seroquel, AstraZeneca
Most Recently Shared on December 7, 2009 at 4:43 pm By:
MPR News: Seroquel XR approved for adjunctive treatment of major depressive disorder (MDD): Seroquel XR (quetiapine... http://bit.ly/8tfaNR
US FDA Approves SEROQUEL XR(R) For Add-On Treatment Of Major Depressive Disorder
medicalnewstoday.com — “Astrazeneca (nyse: azn) announced that the us food and drug administration (fda) has approved once-daily seroquel xr® (quetiapine fumarate) extended release tablets as adjunctive (add-on) tre” View full resource at medicalnewstoday.com
Most Recently Shared on December 5, 2009 at 12:19 pm By:
MNT Depression News Health News
US FDA Approves SEROQUEL XR(R) For Add-On Treatment Of Major Depressive Disorder: AstraZeneca (NYSE: AZN) annou.. http://bit.ly/7L8u0I
Advertisement
